A recent study describes a role for hypoxic signaling in the small intestine in the etiology of nonalcoholic fatty liver disease (NAFLD) and suggests that HIF-2α inhibitors may be an effective option for the treatment of this disease.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Flegal, K.M., Kruszon-Moran, D., Carroll, M.D., Fryar, C.D. & Ogden, C.L. J. Am. Med. Assoc. 315, 2284–2291 (2016).
Younossi, Z. et al. Nat. Rev. Gasroenterol. Hepatol. http://dx.doi.org/10.1038/nrgastro.2017.109 (2017).
Xie, C. et al. Nat. Med. 23, 1298–1308 (2017).
Pagadala, M., Kasumov, T., McCullough, A.J., Zein, N.N. & Kirwan, J.P. Trends Endocrinol. Metab. 23, 365–371 (2012).
Rankin, E.B. et al. Mol. Cell. Biol. 29, 4527–4538 (2009).
Taniguchi, C.M. et al. Nat. Med. 19, 1325–1330 (2013).
Wei, K. et al. Nat. Med. 19, 1331–1337 (2013).
Ramakrishnan, S.K. et al. Cell Metab. 23, 505–516 (2016).
Hosogai, N. et al. Diabetes 56, 901–911 (2007).
Lee, K.Y., Gesta, S., Boucher, J., Wang, X.L. & Kahn, C.R. Cell Metab. 14, 491–503 (2011).
Martínez-Sáez, O., Gajate Borau, P., Alonso-Gordoa, T., Molina-Cerrillo, J. & Grande, E. Crit. Rev. Oncol. Hematol. 111, 117–123 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
LaGory, E., Giaccia, A. Long-range hypoxia signaling in NAFLD. Nat Med 23, 1251–1252 (2017). https://doi.org/10.1038/nm.4436
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4436